Jokubaitis, V. G. Et Al. 2013. Does switching to fingolimod from natalizumab result in short-term relapse exacerbation?. 29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS , (Copenhagen, Denmark), 55-56.

Jokubaitis, V. G., Li, V., Kalincik, T., Izquierdo, G., Hodgkinson, S., Alroughani, R., ... Lechner-Scott, J.(2013). Does switching to fingolimod from natalizumab result in short-term relapse exacerbation? . 29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS (pp.55-56). Copenhagen, Denmark

Jokubaitis, V. Et Al. "Does switching to fingolimod from natalizumab result in short-term relapse exacerbation?," 29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS, Copenhagen, Denmark, 2013

Jokubaitis, V. G. Et Al. "Does switching to fingolimod from natalizumab result in short-term relapse exacerbation?." 29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS , Copenhagen, Denmark, pp.55-56, 2013

Jokubaitis, V. G. Et Al. (2013) . "Does switching to fingolimod from natalizumab result in short-term relapse exacerbation?." 29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS , Copenhagen, Denmark, pp.55-56.

@conferencepaper{conferencepaper, author={V. G. Jokubaitis Et Al. }, title={Does switching to fingolimod from natalizumab result in short-term relapse exacerbation?}, congress name={29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS}, city={Copenhagen}, country={Denmark}, year={2013}, pages={55-56} }